🇺🇸 FDA
Pipeline program

idronoxil

CDR0000068802

Phase 1 small_molecule completed

Quick answer

idronoxil for Unspecified Adult Solid Tumor, Protocol Specific is a Phase 1 program (small_molecule) at KAZIA THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
KAZIA THERAPEUTICS LTD
Indication
Unspecified Adult Solid Tumor, Protocol Specific
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials